AGEN 1721
Alternative Names: AGEN-1721Latest Information Update: 13 Dec 2024
Price :
$50 *
At a glance
- Originator Agenus
- Class Antineoplastics; Immunotherapies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Fibroblast activation protein antagonists; T lymphocyte stimulants; Transforming growth factor beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours